Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
Khitri AR, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Kowey PR. Khitri AR, et al. Among authors: kulakowski p. J Cardiovasc Electrophysiol. 2012 May;23(5):462-72. doi: 10.1111/j.1540-8167.2011.02234.x. Epub 2011 Dec 15. J Cardiovasc Electrophysiol. 2012. PMID: 22171925 Clinical Trial.
Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions.
Gojkovic O, Aliot EM, Capucci A, Connolly SJ, Crijns H, Hohnloser SH, Kulakowski P, Roy D, Radzik D, Singh BN, Kowey PR. Gojkovic O, et al. Among authors: kulakowski p. Heart Rhythm. 2012 Feb;9(2):217-224.e2. doi: 10.1016/j.hrthm.2011.09.073. Epub 2011 Oct 4. Heart Rhythm. 2012. PMID: 21978965 Clinical Trial.
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH; ALPHEE Study Investigators. Kowey PR, et al. Among authors: kulakowski p. Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14. Circulation. 2011. PMID: 22082672 Clinical Trial.
Bipolar Radiofrequency Ablation of Typical Atrial Flutter.
Futyma P, Futyma M, Maciołek M, Kułakowski P. Futyma P, et al. Among authors: kulakowski p. J Cardiovasc Electrophysiol. 2016 Jul;27(7):874-5. doi: 10.1111/jce.12908. Epub 2016 Feb 4. J Cardiovasc Electrophysiol. 2016. PMID: 27405451 No abstract available.
Guidelines on management (diagnosis and treatment) of syncope--update 2004.
Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Masotti G, Moya A, Raviele A, Sutton R, Theodorakis G, Ungar A, Wieling W; Task Force on Syncope, European Society of Cardiology. Brignole M, et al. Among authors: kulakowski p. Europace. 2004 Nov;6(6):467-537. doi: 10.1016/j.eupc.2004.08.008. Europace. 2004. PMID: 15519256 No abstract available.
Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registry.
Balabanski T, Brugada J, Arbelo E, Laroche C, Maggioni A, Blomström-Lundqvist C, Kautzner J, Tavazzi L, Tritto M, Kulakowski P, Kalejs O, Forster T, Villalobos FS, Dagres N; ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators Group. Balabanski T, et al. Among authors: kulakowski p. Europace. 2019 Dec 1;21(12):1802-1808. doi: 10.1093/europace/euz216. Europace. 2019. PMID: 31693093
238 results